#117 new
Gemini Smith

Half-life Extension Service by Genetic Manipulation

Reported by Gemini Smith | February 23rd, 2024 @ 02:20 AM

Studies conducted recently indicate that a molecule can become highly protease resistant in vivo by substituting just one amino acid. Long-acting interferon beta preparation has made use of the point mutation of interferon. A phase 1 trial was initiated for an enhanced somatropin formulation based on genetic alteration. Numerous successes attest to the fact that point mutation has emerged as a novel technique for improving the pharmacokinetics of proteins and is frequently employed in therapeutic protein research. The drug development market has high expectations for half-life extension by genetic manipulation as a unique, practical, and one-stop solution for half-life extension.

No comments found

Please Sign in or create a free account to add a new ticket.

With your very own profile, you can contribute to projects, track your activity, watch tickets, receive and update tickets through your email and much more.

New-ticket Create new ticket

Create your profile

Help contribute to this project by taking a few moments to create your personal profile. Create your profile »


Shared Ticket Bins

People watching this ticket